Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening for Severe Hepatic Fibrosis by FibroScan in a Population Presenting a Severe Psychiatric Disorder Under Treatment for at Least Two Years.

NCT05965232 is registered in ClinicalTrials.gov with Centre Hospitalier Esquirol as lead sponsor.

NCT NCT05965232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05965232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening for Severe Hepatic Fibrosis by FibroScan in a Population Presenting a Severe Psychiatric Disorder Under Treatment for at Least Two Years.
Lead sponsor
Centre Hospitalier Esquirol
Phase
Observational
Overall status
Completed
Start date
October 26, 2017
Completion date
July 12, 2021
Enrollment
385 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar i disorder, most recent episode mixed, in remission, depression psychotic feature, mood-incongruent delusion, severe bipolar i disorder (diagnosis)